Efficacy of Octreotide-LAR in Dieting Women with Abdominal Obesity and Polycystic Ovary Syndrome | Zendy

Alessandra Gambineri | Zendy; Laura Patton | Zendy; Rosaria De Iasio | Zendy; B Cantelli | Zendy; Graciela Estela Cognini | Zendy; Marco Filicori | Zendy; Antonina Barreca | Zendy; Evanthia DiamantiKandarakis | Zendy; Uberto Pagotto | Zendy; Renato Pasquali | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy of Octreotide-LAR in Dieting Women with Abdominal Obesity and Polycystic Ovary Syndrome

Author(s) -

Alessandra Gambineri,

Laura Patton,

Rosaria De Iasio,

B Cantelli,

Graciela Estela Cognini,

Marco Filicori,

Antonina Barreca,

Evanthia DiamantiKandarakis,

Uberto Pagotto,

Renato Pasquali

Publication year - 2005

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2004-2490

Subject(s) - octreotide , medicine , polycystic ovary , endocrinology , placebo , somatostatin , hirsutism , context (archaeology) , insulin , insulin resistance , biology , paleontology , alternative medicine , pathology

Somatostatin reduces LH, GH, and insulin, and somatostatin receptors are present at the ovarian level; somatostatin analogs are thus potential candidates for treatment of the polycystic ovary syndrome (PCOS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research